|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/00 | |
| A61K 31/7064 | |||
| A61K 39/395 | |||
| A61K 47/48 | |||
| C07K 16/28 |
| (11) | Number of the document | 2211885 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08837451.7 |
| Date of filing the European patent application | 2008-10-08 | |
| (97) | Date of publication of the European application | 2010-08-04 |
| (45) | Date of publication and mention of the grant of the patent | 2015-07-29 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/079224 |
| Date | 2008-10-08 |
| (87) | Number | WO 2009/048967 |
| Date | 2009-04-16 |
| (30) | Number | Date | Country code |
| 979594 P | 2007-10-12 | US | |
| 27668 P | 2008-02-11 | US | |
| 40641 P | 2008-03-28 | US |
| (72) |
OFLAZOGLU, Ezogelin, US
SIEVERS, Eric, US
GERBER, Hans-Peter, US
|
| (73) |
Seattle Genetics, Inc.,
21823 30th Drive, S.E., Bothell, WA 98021,
US
|
| (54) | COMBINATION THERAPY WITH ANTIBODY-DRUG CONJUGATES |
| COMBINATION THERAPY WITH ANTIBODY-DRUG CONJUGATES |